ID: ALA609800

Max Phase: Preclinical

Molecular Formula: C18H23N4O9P

Molecular Weight: 470.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccn(C2O[C@H](COP(=O)(O)N[C@@H](Cc3ccccc3)C(=O)O)[C@@H](O)[C@H]2O)c(=O)n1

Standard InChI:  InChI=1S/C18H23N4O9P/c19-13-6-7-22(18(27)20-13)16-15(24)14(23)12(31-16)9-30-32(28,29)21-11(17(25)26)8-10-4-2-1-3-5-10/h1-7,11-12,14-16,23-24H,8-9H2,(H,25,26)(H2,19,20,27)(H2,21,28,29)/t11-,12+,14+,15+,16?/m0/s1

Standard InChI Key:  GVVQXLLUBYSMOZ-QLTCMSEGSA-N

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 470.38Molecular Weight (Monoisotopic): 470.1203AlogP: -1.15#Rotatable Bonds: 9
Polar Surface Area: 206.46Molecular Species: ACIDHBA: 10HBD: 6
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.44CX Basic pKa: CX LogP: -1.57CX LogD: -7.24
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.24Np Likeness Score: 0.96

References

1. Whalen LJ, McEvoy KA, Halcomb RL..  (2003)  Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.,  13  (2): [PMID:12482445] [10.1016/s0960-894x(02)00735-7]

Source